BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1320670)

  • 1. Immunoreactivity for the beta chain of the platelet-derived growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium.
    Ramael M; Buysse C; van den Bossche J; Segers K; van Marck E
    J Pathol; 1992 May; 167(1):1-4. PubMed ID: 1320670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactivity for P-170 glycoprotein in malignant mesothelioma and in non-neoplastic mesothelium of the pleura using the murine monoclonal antibody JSB-1.
    Ramael M; van den Bossche J; Buysse C; van Meerbeeck J; Segers K; Vermeire P; van Marck E
    J Pathol; 1992 May; 167(1):5-8. PubMed ID: 1352542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived growth factor receptor immunoreactivity in mesothelioma and nonneoplastic mesothelial cells in serous effusions.
    Ascoli V; Scalzo CC; Facciolo F; Nardi F
    Acta Cytol; 1995; 39(4):613-22. PubMed ID: 7543232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity for p53 protein in malignant mesothelioma and non-neoplastic mesothelium.
    Ramael M; Lemmens G; Eerdekens C; Buysse C; Deblier I; Jacobs W; van Marck E
    J Pathol; 1992 Dec; 168(4):371-5. PubMed ID: 1484318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactivity for c-fos and c-myc protein with the monoclonal antibodies 14E10 and 6E10 in malignant mesothelioma and non-neoplastic mesothelium of the pleura.
    Ramael M; Van den Bossche J; Buysse C; Deblier I; Segers K; Van Marck E
    Histol Histopathol; 1995 Jul; 10(3):639-43. PubMed ID: 7579812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo.
    Langerak AW; De Laat PA; Van Der Linden-Van Beurden CA; Delahaye M; Van Der Kwast TH; Hoogsteden HC; Benner R; Versnel MA
    J Pathol; 1996 Feb; 178(2):151-60. PubMed ID: 8683381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical staining of ras oncogene product in neoplastic and non-neoplastic mesothelial tissues: immunoreactivity for N-ras and lack of immunohistochemical staining for Ha-ras and K-ras.
    Ramael M; Deblier I; Eerdekens C; Lemmens G; Jacobs W; Van Marck E
    J Pathol; 1993 Apr; 169(4):421-4. PubMed ID: 8501538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression.
    Kumar-Singh S; Weyler J; Martin MJ; Vermeulen PB; Van Marck E
    J Pathol; 1999 Sep; 189(1):72-8. PubMed ID: 10451491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2.
    Attanoos RL; Griffin A; Gibbs AR
    Histopathology; 2003 Sep; 43(3):231-8. PubMed ID: 12940775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme.
    Dorai T; Kobayashi H; Holland JF; Ohnuma T
    Mol Pharmacol; 1994 Sep; 46(3):437-44. PubMed ID: 7935323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived growth factor receptor (beta-subunit) immunoreactivity in soft tissue tumors.
    Palman C; Bowen-Pope DF; Brooks JJ
    Lab Invest; 1992 Jan; 66(1):108-15. PubMed ID: 1309926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis.
    Kumar-Singh S; Segers K; Rodeck U; Backhovens H; Bogers J; Weyler J; Van Broeckhoven C; Van Marck E
    J Pathol; 1997 Jan; 181(1):67-74. PubMed ID: 9072005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human malignant mesothelioma cell lines express PDGF beta-receptors whereas cultured normal mesothelial cells express predominantly PDGF alpha-receptors.
    Versnel MA; Claesson-Welsh L; Hammacher A; Bouts MJ; van der Kwast TH; Eriksson A; Willemsen R; Weima SM; Hoogsteden HC; Hagemeijer A
    Oncogene; 1991 Nov; 6(11):2005-11. PubMed ID: 1658707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma.
    Coltrera MD; Wang J; Porter PL; Gown AM
    Cancer Res; 1995 Jun; 55(12):2703-8. PubMed ID: 7780988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical distribution patterns of epidermal growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium.
    Ramael M; Segers K; Buysse C; Van den Bossche J; Van Marck E
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(3):171-5. PubMed ID: 1926758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium.
    Dabrow MB; Francesco MR; McBrearty FX; Caradonna S
    Gynecol Oncol; 1998 Oct; 71(1):29-37. PubMed ID: 9784315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential immunohistochemical staining for retinoblastoma protein with the antibodies C15 and 1F8 in malignant mesothelioma.
    Ramael M; Segers K; Van Marck E
    Pathol Res Pract; 1994 Feb; 190(2):138-41. PubMed ID: 7520164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of platelet-derived growth factor and its receptors in soft tissue malignant fibrous histiocytoma.
    Yamamoto T; Akisue T; Marui T; Fujita I; Matsumoto K; Kawamoto T; Hitora T; Nakatani T; Nagira K; Kurosaka M
    Anticancer Res; 2003; 23(5b):4325-8. PubMed ID: 14666646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal expression of platelet-derived growth factor beta-receptor and platelet-derived growth factor B-chain in colorectal cancer.
    Lindmark G; Sundberg C; Glimelius B; PĂ„hlman L; Rubin K; Gerdin B
    Lab Invest; 1993 Dec; 69(6):682-9. PubMed ID: 8264231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.